Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Targeting the serotonin 2C receptor for the treatment of obesity and type 2 diabetes.

× No keyword cloud information.

5 in total

1. Evidence for a role of 5-HT2C receptors in the motor aspects of performance, but not the efficacy of food reinforcers, in a progressive ratio schedule.

Authors: G Bezzina; S Body; T H C Cheung; C L Hampson; C M Bradshaw; J C Glennon; E Szabadi
Journal: Psychopharmacology (Berl) Date: 2014-08-19 Impact factor: 4.530

2. A randomized, double-blind, placebo-controlled pilot study of naltrexone to counteract antipsychotic-associated weight gain: proof of concept.

Authors: Cenk Tek; Joseph Ratliff; Erin Reutenauer; Rohan Ganguli; Stephanie S O'Malley
Journal: J Clin Psychopharmacol Date: 2014-10 Impact factor: 3.153

3. Glucagon-Like Peptide 1 and Its Analogs Act in the Dorsal Raphe and Modulate Central Serotonin to Reduce Appetite and Body Weight.

Authors: Rozita H Anderberg; Jennifer E Richard; Kim Eerola; Lorena López-Ferreras; Elin Banke; Caroline Hansson; Hans Nissbrandt; Filip Berqquist; Fiona M Gribble; Frank Reimann; Ingrid Wernstedt Asterholm; Christophe M Lamy; Karolina P Skibicka
Journal: Diabetes Date: 2017-01-05 Impact factor: 9.461

4. Investigating the safety and efficacy of naltrexone for anti-psychotic induced weight gain in severe mental illness: study protocol of a double-blind, randomized, placebo-controlled trial.

Authors: Cenk Tek; Sinan Guloksuz; Vinod H Srihari; Erin L Reutenauer
Journal: BMC Psychiatry Date: 2013-06-27 Impact factor: 3.630

Review 5. Safety and efficacy of naltrexone for weight loss in adult patients - a systematic review.

Authors: Agnieszka Kulak-Bejda; Grzegorz Bejda; Napoleon Waszkiewicz
Journal: Arch Med Sci Date: 2020-09-10 Impact factor: 3.318

5 in total